Neuromuscular Research Grant Competitions from Defeat Duchenne Canada and Myotonic Dystrophy Foundation You Can Apply For Today!
Defeat Duchenne Canada:
Defeat Duchenne Canada is now accepting Letters of Intent (LOI) for its 2025 Research Grant Cycle! As the country’s leading funder of Duchenne muscular dystrophy (DMD) specific research, they are committed to supporting groundbreaking projects that improve care, accelerate treatments, and bring us closer to a cure.
The submission portal opened on March 31, 2025, and researchers worldwide are invited to begin the process by submitting LOI by April 28, 2025. Don’t miss this opportunity to apply for funding for innovative Duchenne research.
Learn more and apply today: https://defeatduchenne.ca/granting-process/
Myotonic Dystrophy Foundation:
The Myotonic Dystrophy Foundation (MDF) supports scientific investigations to enhance the quality of life of people living with myotonic dystrophy and advance research focused on finding treatments and a cure for this disease. As a part of this effort, the MDF offers a number of funding opportunities for DM researchers.
2026 Doctoral and Postdoctoral Research Fellowships
Proposals Due: September 5, 2025
Through this effort, the MDF intends to fund doctoral and postdoctoral research fellowships for projects that focus on basic, translational, and/or clinical research or care in myotonic dystrophy.
Read the fellowship guidelines here!
2026 Early Career Scholar Grant
Proposals Due: September 5, 2025
MDF is accepting applications for Early Career Scholar awards to support the retention of passionate early career researchers in the DM field. These awards are available in both basic/translational science and clinical research streams. Through these awards, MDF seeks to retain early-career scholars who are passionate about DM research.
Read next...
NMD4C Hosts 3rd Annual Basic Research Summer School at uOttawa!
From June 8 to 10, 2026, we hosted the 3rd annual NMD4C Basic Research Summer School at the University of Ottawa. The program supported 28 neuromuscular research trainees (graduate students and postdoctoral fellows) from across Canada and focused on developing practical skills, strengthening core knowledge in neuromuscular research, and providing opportunities to present and discuss their work. Through a combination of tutorials, lectures, hands-on workshops in cutting-edge wet lab techniques, flash talks, and both structured and informal networking, participants engaged with faculty, exchanged ideas, and built connections across institutions and career stages.
New Publication from the NMD4C Clinical Trial Network Strengthens Trial Capacity in Canada
We are pleased to share a new publication from the NMD4C Clinical Trial Network led by Kerri Lynn Schellenberg, Homira Osman, Maria Masnata, Rhiannon Hicks, Corinne Kagan, Ana Stosic, Stacey Lintern, Erin Beattie, Drs. Hanns Lochmüller, Craig Campbell, and Jean K Mah. This work focuses on the implementation of a coordinated Canadian neuromuscular clinical trial network to enhance trial readiness, capacity, and access in rare disease research.
Canadian-Led Phase II Studies Advance Vamorolone Evidence in Duchenne Muscular Dystrophy
NMD4C investigators contributed to two phase II studies evaluating vamorolone in boys with Duchenne muscular dystrophy across early childhood and adolescence, demonstrating safety, favorable pharmacokinetics, and potential efficacy. Led by Dr. Jean Mah and conducted across Canadian clinical trial sites with national and industry collaborators, the findings supported Health Canada approval of vamorolone as the first treatment for DMD in Canada. Leaders from both the clinical and patient advocacy communities, including Defeat Duchenne Canada, highlighted the impact of collaboration among patients, families, clinicians, and researchers in advancing care and improving access to new therapies.